AI-Readiness 101: AI Success Starts with Understanding Your Data
Everyone wants AI.
Medical Information
What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine
When animal health companies expand globally, attention typically focuses on product registration, market access, supply chain planning, and commercialization. Medical information is often considered...
Quality & Compliance
Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture
The Evolving Global Regulatory Landscape As the pharmaceutical industry continues to operate in an increasingly globalized environment, regulatory oversight has evolved into a more interconnected,...
Regulatory Sciences
Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and Market Opportunities
Navigating Market Access in Eastern Europe The role of the Marketing Authorization Holder (MAH) is central to bringing pharmaceutical products to patients in the European Union and associated...
Quality & Compliance
AI in GxP: Recurring Compliance Gaps
What challenges are we seeing as life sciences organizations expand AI adoption? Artificial intelligence (AI) is increasingly embedded in compliance areas like medical information, pharmacovigilance,...
Digital Transformation
Digital Transformation First: Why AI Investment Depends on Strategy, Data, and Operational Readiness
Our recent LinkedIn poll asked a simple question: What is the first step in a digital transformation journey? The response was decisive. Seventy percent of respondents identified strategy definition...
Full-Service CRO
Is Your Clinical Trial at Risk: When to Consider a Rescue Strategy
Clinical trials rarely unravel because of one isolated event. Many continue to progress with underlying issues that gradually impact timelines, data quality, and overall study confidence. A missed...
Regulatory Sciences
Top 7 QMSR Readiness Gaps Medical Device Manufacturers Should Assess Before an FDA Inspection
FDA's New Quality Management System Regulation Raises the Bar for Inspection Readiness FDA's Quality Management System Regulation (QMSR), which became effective on February 2, 2026, represents one of...
Pharmacovigilance
Efficiency and Compliance: Mastering Legal Case Processing in Pharmacovigilance
In the complex landscape of modern pharmacovigilance (PV), the intersection of patient safety and legal litigation poses unique challenges for Marketing Authorization Holders (MAHs). While...
Regulatory Sciences
EMA PRIME Eligibility: Accelerating Access to the European Union Market
Developing innovative medicines requires more than scientific excellence. It also requires a regulatory strategy that supports efficient development, aligns with evolving regulatory expectations, and...
Full-Service CRO
From Feasibility to First Patient In: Streamlining Study Start‑Up with Confidence
Clinical trial timelines are rarely lost during study conduct but are lost long before the first patient is screened. Delays in study startup often begin at country selection and feasibility where...
Quality & Compliance
QMSR Explained: Key Changes from FDA QSR to the New Quality Management System Regulation
The FDA's transition from the long-standing Quality System Regulation (QSR, 21 CFR Part 820) to the new Quality Management System Regulation (QMSR) represents one of the most significant regulatory...
Full-Service CRO
Building Relationships with Sites: The Hidden Driver of Faster Start-Ups
Humanized content about engagement strategies with sites and investigators. The Study Start Up (SSU) phase of clinical trials always feels very chaotic when you are in the “thick of it” with...
Regulatory Sciences
FDA Weighs in on Popular Peptides
In about a week, the committee that advises the FDA on pharmacy compounding will hold a public meeting on several peptides that are popular in sports medicine and do-it-yourself physical...
Regulatory Sciences
First Joint Clinical Assessments (JCAs): Key Lessons for EU HTA
The First JCAs Are Revealing More Than a New Process: Early Lessons and JCA Readiness As the first Joint Clinical Assessments (JCAs) moved from planning into practice, a clearer picture is emerging...
Full-Service CRO
Turning Regulatory Complexity into Predictable Study Start-Up Execution
Regulatory complexity is unavoidable in global clinical development. The differentiator is not whether organizations face complexity, it is how effectively they operationalize it. Across Europe,...
